InvisiDerm Healthcare Unveils Successful Transdermal Microcirculation Application Results with D`OXYVA

Pasadena, CA (PRWEB) March 27, 2013

InvisiDerm Healthcare (InvisiDerm), developer and manufacturer of noninvasive gas and drug delivery methods, recently presented the results of its successful clinical study with its innovative D`OXYVA